Ardelyx Inc. (ARDX) Financial Statements (2025 and earlier)

Company Profile

Business Address 34175 ARDENWOOD BLVD.
FREMONT, CA 94555
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments185,961202,578184,299165,080127,579130,373
Cash and cash equivalents41,89036,14721,47033,76730,05892,487
Short-term investments144,071166,431162,829131,31397,52137,886
Receivables37,24128,16222,03143,2639,10912,120
Inventory, net of allowances, customer advances and progress billings83,43278,85849,48747,49847,91244,947
Inventory83,43278,85849,48747,49847,91244,947
Other undisclosed current assets(43,614)(51,659)(9,706)(14,625)(22,482)(20,393)
Total current assets:263,020257,939246,111241,216162,118167,047
Noncurrent Assets
Inventory, Noncurrent69,67669,04537,03938,97440,29540,124
Operating lease, right-of-use asset4,3244,6415,5896,5237,0537,972
Property, plant and equipment1,0161,0191,0091,1161,0641,102
Other noncurrent assets5,4525,5033,5961,550673774
Other undisclosed noncurrent assets  4,2354,235   
Total noncurrent assets:80,46884,44351,46848,16349,08549,972
TOTAL ASSETS:343,488342,382297,579289,379211,203217,019
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,33924,00423,73516,09312,17415,587
Accounts payable10,88117,27711,1387,7365,29410,513
Accrued liabilities10,4586,72712,5978,3576,8805,074
Deferred revenue10,8296,5867,1824,0725,9595,545
Debt     27,05226,880
Other liabilities   1,366   
Other undisclosed current liabilities30,26826,30518,11023,36416,50415,051
Total current liabilities:62,43656,89550,39343,52961,68963,063
Noncurrent Liabilities
Long-term debt and lease obligation100,24999,83449,82227,229  
Long-term debt, excluding current maturities100,24999,83449,82227,229  
Liabilities, other than long-term debt10,70912,88110,36913,34713,16216,312
Deferred revenue9,61312,1038,64410,2909,23811,498
Other liabilities    170172 
Operating lease, liability1,0967781,7252,8873,7524,814
Other undisclosed noncurrent liabilities23,10421,88120,17914,11313,19112,223
Total noncurrent liabilities:134,062134,59680,37054,68926,35328,535
Total liabilities:196,498191,491130,76398,21888,04291,598
Equity
Equity, attributable to parent146,990150,891166,816191,161123,161125,421
Common stock232323232221
Additional paid in capital1,036,2441,023,6101,012,7731,008,741947,380932,330
Accumulated other comprehensive income (loss)(101)(20)224(201)(210)(20)
Accumulated deficit(889,176)(872,722)(846,204)(817,402)(824,031)(806,910)
Total equity:146,990150,891166,816191,161123,161125,421
TOTAL LIABILITIES AND EQUITY:343,488342,382297,579289,379211,203217,019

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues73,22246,02334,36356,39122,33311,369
Cost of revenue(9,436)(7,128)(5,077)(7,692)(3,489)(1,537)
Cost of goods and services sold(9,436)(7,128)(5,077)(7,692)(3,489) 
Gross profit:63,78638,89529,28648,69918,8449,832
Operating expenses(77,416)(63,573)(57,272)(41,301)(35,468)(35,896)
Operating income (loss):(13,630)(24,678)(27,986)7,398(16,624)(26,064)
Nonoperating income2,1452,3392,3221,4601,5461,302
Interest and debt expense(3,326)(2,356)(1,740)(1,107)(1,075)(1,028)
Income (loss) from continuing operations before equity method investments, income taxes:(14,811)(24,695)(27,404)7,751(16,153)(25,790)
Other undisclosed loss from continuing operations before income taxes(1,576)(1,702)(1,065)(922)(968)(969)
Income (loss) from continuing operations before income taxes:(16,387)(26,397)(28,469)6,829(17,121)(26,759)
Income tax expense(67)(121)(333)(200) (14)
Net income (loss) available to common stockholders, diluted:(16,454)(26,518)(28,802)6,629(17,121)(26,773)

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net income (loss):(16,454)(26,518)(28,802)6,629(17,121)(26,773)
Comprehensive income (loss):(16,454)(26,518)(28,802)6,629(17,121)(26,773)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(81)(244)4259(190)34
Comprehensive income (loss), net of tax, attributable to parent:(16,535)(26,762)(28,377)6,638(17,311)(26,739)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: